NASDAQ:BBH - VanEck Vectors Biotech ETF Stock Price, News & Analysis

-1.22 (-0.99 %)
(As of 09/18/2019 02:11 PM ET)
Today's Range
Now: $121.89
50-Day Range
MA: $123.91
52-Week Range
Now: $121.89
Volume5,893 shs
Average Volume13,367 shs
Market Capitalization$341.29 million
P/E RatioN/A
Dividend Yield0.45%

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Biotech ETF
Tax ClassificationRegulated Investment Company
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Biotech 25 Index
FocusHealth Care
Development LevelDeveloped Markets

Fund Statistics

Assets Under Management$357.00 million
Average Daily Volume$23,202.10

ETF Expenses

Management Fee0.35%
Other Expenses0.04%
Total Expenses0.39%
Fee Waiver-0.04%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Lead Market MakerVirtu Financial

Receive BBH News and Ratings via Email

Sign-up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

Geographic Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Currency Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Sector Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)
Industry Exposure of VanEck Vectors Biotech ETF (NASDAQ:BBH)

VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions

What is VanEck Vectors Biotech ETF's stock symbol?

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

How often does VanEck Vectors Biotech ETF pay dividends? What is the dividend yield for VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF announced an annual dividend on Friday, November 16th. Investors of record on Friday, December 21st will be paid a dividend of $0.537 per share on Thursday, December 27th. This represents a yield of 0.44%. The ex-dividend date is Thursday, December 20th. View VanEck Vectors Biotech ETF's Dividend History.

Has VanEck Vectors Biotech ETF been receiving favorable news coverage?

Press coverage about BBH stock has been trending negative on Wednesday, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. VanEck Vectors Biotech ETF earned a media sentiment score of -2.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for VanEck Vectors Biotech ETF.

Who are some of VanEck Vectors Biotech ETF's key competitors?

What other stocks do shareholders of VanEck Vectors Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Arlo Technologies (ARLO), International Game Technology (IGT), SPDR S&P 500 ETF Trust (SPY), Alliance MMA (AMMA), Ashford (AINC), Allied Healthcare Products (AHPI), Adobe (ADBE), B&M European Value Retail (BME), Anglo American (AAL) and Deutsche Bank (DBK).

Who are VanEck Vectors Biotech ETF's major shareholders?

VanEck Vectors Biotech ETF's stock is owned by a number of of institutional and retail investors. Top institutional investors include UBS Group AG (2.01%), Morgan Stanley (1.68%), Royal Bank of Canada (1.48%), Citadel Advisors LLC (1.37%), Murphy Capital Management Inc. (1.30%) and Bank of America Corp DE (1.32%).

Which major investors are selling VanEck Vectors Biotech ETF stock?

BBH stock was sold by a variety of institutional investors in the last quarter, including Ellis Investment Partners LLC, Morgan Stanley, Citadel Advisors LLC, Wells Fargo & Company MN, Commonwealth Equity Services LLC, Murphy Capital Management Inc., LPL Financial LLC and Tower Research Capital LLC TRC .

Which major investors are buying VanEck Vectors Biotech ETF stock?

BBH stock was acquired by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Bank of America Corp DE, Pacific Sun Financial Corp, Bailard Inc., Integrated Wealth Concepts LLC, Mogy Joel R Investment Counsel Inc., Truvestments Capital LLC and First Manhattan Co..

How do I buy shares of VanEck Vectors Biotech ETF?

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is VanEck Vectors Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $121.89.

How big of a company is VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF has a market capitalization of $341.29 million. View Additional Information About VanEck Vectors Biotech ETF.

MarketBeat Community Rating for VanEck Vectors Biotech ETF (NASDAQ BBH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about VanEck Vectors Biotech ETF and other stocks. Vote "Outperform" if you believe BBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/18/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel